J. Langer et al. / Journal of Organometallic Chemistry 689 (2004) 2952–2962
2959
1
addition of an aqueous solution of sodium carbonate
(20 ml) and rapid stirring of the resulting mixture for
2 h. Then THF was removed in vacuum and the aque-
ous phase was extracted with heptane (3·20 ml). The
collected organic layers were concentrated and the 5
was separated by column chromatography on silica gel
(heptane/ethyl acetate 10:1) as nearly colorless oil. Yield:
tained 7 together with DMF. Yield: 100 mg (14%). H
NMR (400 MHz, CDCl3, 25 ꢁC): d=1.17 (d,
3JH,H =6.9 Hz, 3H, CH3), 1.73 (m, 1H, CH H0), 2.13
(m, 1H, CHH0), 2.35 (m, 2H, CHH0–COO), 3.56 (m,
1H, CH–CH3), 7.42 (m, 2H, m-CH Ph), 7.51 (m, 1H,
p-CH Ph), 7.93 (m, 2H, o-CH Ph) 8.2-9.5 (br, 1H,
COOH) ppm. 13C{1H} NMR (50 MHz, CDCl3, 25
ꢁC): d=17.3 (CH3), 28.1 (CH2), 31.6 (CH2–COO), 43.6
(CH), 128.4 (2·o-CH Ph), 128.7 (2·m-CH Ph), 133.0
(p-CH Ph), 136.3 (i-C Ph), 177.1 (COO), 203.7 (C‚O)
ppm. MS (DEI): m/z (%)=207 [M+ +1] (18), 206 [M+]
(34), 189 [M+–OH] (100), 105 [Ph–CO+] (100).
1
400 mg (53%). IR (nujol, cmꢀ1): m(C‚O) 1731 (s). H
NMR (400 MHz, CDCl3, 25 ꢁC): d=0.95 (t,
3
3JH,H =7.4 Hz, 3H, CH3), 1.05 (t, JH,H =7.4 Hz, 3H,
3
CH3), 2.16 (q, JH,H =7.4 Hz, 2H, CH2), 2.31 (s, 3H,
3
CH3 p-tolyl), 2.38 (q, JH,H =7.4 Hz, 2H, CH2), 3.75
(s, 3H, COOCH3), 7.09 (AA0BB0, 2H, CH tolyl), 7.30
(AA0BB0, 2H, CH tolyl) ppm. 13C{1H} NMR (100
MHz, CDCl3, 25 ꢁC): d=13.6 (CH3), 13.7 (CH3), 21.1
(CH3 tolyl), 23.8 (CH2), 24.8 (CH2), 51.5 (CH3–O),
129.6 (2 ·CH tolyl), 130.0 (i-C–S tolyl), 132.9 (‚C<),
133.2 (2·CH tolyl), 137.9 (i-C–CH3 tolyl), 145.3
(>C‚), 169.2 (COO) ppm. MS (DEI): m/z (%)=265
[M+ +1] (21), 264 [M+] (100), 233 [M+–OCH3] (51),
141 [M+–S-tolyl] (12), 109 (12).
4.8.2. (b) From [(bipy)Ni(C2H4COO)]
Starting from (2.79 mmol) [(bipy)Ni(C2H4COO)]
(0.80 g, 2.79 mmol) and 2-bromopropiophenone (0.42
ml, 2.76 mmol) in DMF (40 ml) reaction was carried
out analogously to (a). Yield: 40 mg (7%) of 7.
4.9. Synthesis of 3,4-diethyl-6-hydroxy-5-methyl-6-phe-
nyl-5,6-dihydro-2H-pyran-2-one (8)
4.7.4. Dimethyl-5-(p-tolylmercapto)-pent-3-enoic acid
(6)
4.9.1. (a) In DMF
…
…
[(bipy)Ni(C(C2H5)‚C(C2H5)–COO)] (0.64 g, 1.88
mmol) was dissolved in DMF (30 ml) and 2-brompro-
piophenone (0.42 g, 1.97 mmol) was added. The solution
was stirred at ambient temperature overnight and
turned from initial red to green. Following standard
procedure, 5,6-dihydro-2H-pyran-2-one 5 was obtained
as a white solid. Yield: 230 mg (47%). C16H20O3
(260.33) Calc.: C 73.82, H 7.74; Found: C 73.88, H
7.76. IR (KBr, cmꢀ1): m(OH) 3290 (br, s), m(C‚O)
1686(s). 1H NMR (400 MHz, CDCl3, 25 ꢁC): major pair
A solution of [(bipy)Ni(CH2 C(CH3) C(CH3)–
CH2COO)] 3b (0.46 g, 1.35 mmol) and di-p-tolyldisulfide
(0.34 g, 1.38 mmol) in DMF (30 ml) was stirred at am-
bient temperature over night. Usual work up yielded
sticky oil (260 mg). GC/IR, GC/MS analysis (after este-
rification with diazomethane) and 1HNMR (NOESY) of
the crude product showed the presence of (Z)-6 and (E)-
6 beside further minor products. (Z)-6: yield (155 mg,
1
46%). H NMR (200 MHz, CDCl3, 25 ꢁC): d=1.73 (s,
3H, CH3), 1.82 (s, 3H, CH3), 2.30 (s, 3H, CH3 tolyl),
2.89 (s, 2H, CH2), 3.51 (s, 2H, CH2), 7.06 (AA0BB0,
2H, CH tolyl), 7.25 (AA0BB0, 2H, CH tolyl), 8.50–9.50
(br, 1H, COOH) ppm. IR (as methyl ester) (pure, gas
phase, cmꢀ1): 3025, 2959, 2932, m(C‚O) 1756 (s),
1492, 1437, 1251, 1162 (s), 1018, 807. MS (DEI, as me-
thyl ester): m/z (%)=264 [M+] (62), 233 [M+–OCH3] (4),
141 [M+–S-tolyl] (100), 109 (4), 99 (6). (E)-6: yield (45
mg, 13%). IR (as methyl ester) (pure, gas phase,
cmꢀ1): 3024, 2960, 2932, m(C‚O) 1756 (s), 1492, 1438,
1246, 1197, 1151 (s),1018, 805. MS (DEI, as methyl es-
ter): m/z (%)=264 [M+] (51), 233 [M+–OCH3] (4), 205
[M+–COOCH3] (7), 141 [M+–S-tolyl] (100), 123 [tolyl-
S+] (23), 109 (14), 99 (10).
3
of diastereomers (ratio 5:1): d=0.74 (d, JH,H =7.2 Hz,
3H, CH3), 1.08 (t, JH,H =7.5 Hz, 3H, CH3), 1.21 (t,
3
3JH,H =7.6 Hz, 3H, CH3), 2.09 (m, 1H, CH H0), 2.40
(m, 2H, CHH0), 2.54 (m, 1H, CHH0), 2.66 (q,
3JH,H =7.2 Hz, 1H, CH), 3.50 (br, 1H, OH), 7.32–7.45
(m, 3H, m-CH+p-CH Ph), 7.58–7.63 (m, 2H, o-CH
Ph) ppm, minor pair of diastereomers: d=0.73 (t,
3JH,H =7.7 Hz, 3H, CH3), 0.92 (t, JH,H =7.4 Hz, 3H,
3
3
CH3), 1.29 (d, JH,H =7.0 Hz, 3H, CH3), 1,.9 (m, 1H,
CH H0), 2.19–2.40 (m, 3H, CHH0 +CHH0), 2.90 (q,
3JH,H =6.9 Hz, 1H, CH), 3.67 (br, 1H, OH), 7.32–7.45
(m, 3H, m-CH+p-CH Ph), 7.58–7.63 (m, 2H, o-CH
Ph) ppm. 13C{1H} NMR (100 MHz, CDCl3, 25 ꢁC): ma-
jor pair of diastereomers: d=12.3 (CH3), 13.9 (CH3),
16.5 (CH3), 19.9 (CH2), 25.1 (CH2), 42.5 (CH), 102.8
(C–OH), 125.6 (2·m-CH Ph), 125.7 (>C‚), 128.4
(2·o-CH Ph), 128.8 (p-CH Ph), 140.7 (i-C Ph), 157.7
(‚C<), 164.7 (COO) ppm. MS (DEI): m/z (%)]=261
[M+ +1] (21), 243 [M+–OH] (86), 138 [M+–OH–Ph–
CO] (100), 105 [Ph–CO+] (36).
4.8. Benzoylvaleric acid (7) [47]
4.8.1. (a) From [py2Ni(C2H4COO)] (1)
To a solution of 1 (0.98 g, 3.4mmol) in DMF (40 ml)
2-bromopropiophenone (0.52 ml, 3.4 mmol) was added
at r.t. The resulting solution was stirred overnight and
than the reaction mixture was worked up according to
the above standard procedure. The crude product con-
Single crystals suitable for the X-ray diffraction were
obtained from a heptane/THF mixture.